Friday, August 6, 2021
Home Tags Sun Pharma

Tag: Sun Pharma

Sun Pharma, Cassiopea SpA ink agreements for Acne treatment drug

NEW DELHI: Drug major Sun Pharma on Monday said it has signed license and supply agreements with Cassiopea SpA for acne treatment drug...

Sun Pharma, Ferring Pharma sign agreement to launch CARITEC in India

Sun Pharmaceutical Industries announced that one of its wholly owned subsidiaries has entered into a license agreement with Ferring Pharmaceuticals, a subsidiary...

Sun Pharma acquires trademarks of 3 diabetes drug from AstraZeneca

Drug major Sun Pharma on Friday said it has acquired the rights to trademarks of diabetes drug Dapagliflozin under brands Oxra, Oxramet and Oxraduo in India from AstraZeneca Pharma India's parent...

Sun Pharma recalls 50,868 bottles of diabetes drug in US

Drug major Sun Pharma is recalling 50,868 bottles of diabetes drug Metformin HCl extended-release tablets in the US market, according to the US Food and Drug Administration (USFDA).

Lupin, Sun, Jubilant recall generic medicines in US

Lupin, Sun Pharma and Jubilant Cadista are recalling different products in the US, the world’s largest market for medicines, for different reasons.

Sun Pharma, Alembic recall products in the US market

Sun Pharma, Alembic recall products in the US market New Delhi: Leading drug makers Sun Pharma and Alembic Pharmaceuticals are recalling different products...

Govt to pharma firms: Ramp up Remdesivir Mfg to full capacity

The government said that all seven manufacturers of remdesivir in the country have been asked to ramp up production to full capacity...

These 4 Pharma companies invest in ABCD Technologies

Four pharma major companies have subscribed to partnership interest in ABCD Technologies LLP (to be renamed as IndoHealth Services LLP).

Pharma Companies recall these drugs in US

Sun Pharma, Dr Reddy’s Laboratories, Aurobindo Pharma and Jubilant Pharma are recalling products in the US market for various reasons.

Sun Pharma to launch entire range of Epilepsy treatment drug in...

Sun Pharmaceutical Industries announced that the company will introduce the complete range of Brivaracetam dosage forms at an affordable price for epilepsy...

DPCO-2013: Sun Pharma gets price exemption for this FDC

The National Pharmaceuticals Pricing Authority (NPPA) has granted exemption to Sun Pharmaceuticals from the provisions of DPCO, 2013 for its following FDC...

Sun Pharma recalls generic diabetes drug: USFDA

New Delhi: Leading drug maker Sun Pharma is recalling 747 bottles of generic diabetes drug in the US due to possibility of the affected lot containing...

Sun and Marksans Pharma voluntarily recall metformin

The USFDA is alerting patients and health care professionals to two voluntary recalls of extended release (ER) metformin by Marksans Pharma and...

Sun Pharma recalls metformin due to high NDMA levels

Sun Pharmaceutical Industries is voluntarily recalling one lot of RIOMET ER (metformin hydrochloride for extended-release oral suspension), 500 mg per 5 mL...

Sun Pharma launches ILUMYA – Tildrakizumab

Sun Pharmaceutical Industries announced that its wholly-owned Japanese subsidiary has launched ILUMYA subcutaneous injection 100 mg syringe (nonproprietary name: tildrakizumab) in Japan...

Lupin, Sun Pharma recall Lisinopril and Clonazepam respectively

New Delhi: Leading drug makers Lupin and Sun Pharma are recalling different products in the US, according to the US Food and Drug Administration (USFDA).

Sun Pharma launches Favipiravir in India at Rs 35 per tablet

NEW DELHI: Drug major Sun Pharmaceutical Industries on Tuesday said it has launched antiviral drug Favipiravir under the brand name 'FluGuard' for the...

Sun Pharma to acquire Canada’s Aquinox Pharma

Mumbai, Sun Pharmaceutical Industries on Wednesday said that a wholly-owned subsidiary of Taro Pharmaceutical Industries Ltd will acquire Aquinox Pharmaceuticals (Canada) Inc for $8.2...

Sun Pharma testing plant-based drug for COVID-19

BENGALURU: Indian drugmaker Sun Pharmaceutical Industries Ltd said on Friday it was testing a plant-derived drug, AQCH, for the potential treatment of COVID-19 as part...

Sun Pharma gets DCGI nod for clinical trial with Nafamostat

Sun Pharmaceutical Industries has announced that it has received approval from the Drugs Controller General of India (DCGI) to initiate a clinical...

Pharma firm executive booked: Covid-19

Pharma firm executive booked: Covid-19 The Barotiwala police registered a case against an executive of Sun Pharma, who was...

USFDA classifies Sun Pharma as OAI

New Delhi: Drug major Sun Pharmaceutical on Sunday said the US health regulator has classified its Halol facility in Gujarat as Official Action Indicated (OAI).The United States...

Sun Pharma flags hypertension drug shortage

BENGALURU: Indian drugmaker Sun Pharmaceutical Industries Ltd reported a shortage of its generic version of hypertension drug pindolol, due to a lack of...

Sun Pharma likely to set up unit in Pharma City

Hyderabad: India’s largest pharma player Sun Pharma is exploring the possibility of setting up manufacturing facilities at the upcoming Pharma City, Sun Pharma founder and managing director Dilip Shanghvi told. 

Latest posts

Breastfeeding myths: Let’s understand the truth

Breastfeeding myths: Let's understand the truth The best natural food source that changes according to the needs is...

Authors

42 POSTS0 COMMENTS
30 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
6 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS